Medtronic stentless Freestyle® porcine aortic valve replacement
MetadataShow full item record
Biological heart valve prostheses offer the opportunity of avoiding the risk of thromboembolic and hemorrhagic complications due to anticoagulation therapy. Current indications recommend a bioprosthesis for aortic valve replacement in patients of any age, who will not take warfarin or who have major medical contraindications to anticoagulation therapy (Class I), in patients older than 65 years without risk factors for thromboembolism (Class IIa) and in patients under 65 years for lifestyle considerations after detailed discussion of the risks of anticoagulation versus the likelihood of a second valve replacement . © 2010 Steinkopff.
Showing items related by title, author, creator and subject.
Russell, E.; Tran, L.; Baker, R.; Bennetts, J.; Brown, A.; Reid, Christopher; Tam, R.; Walsh, W.; Maguire, G. (2014)Background: Globally, rheumatic heart disease (RHD) remains an important cause of heart disease. In Australia it particularly affects older non-Indigenous Australians and Aboriginal Australians and/or Torres Strait Islander ...
Ennker, I.; Albert, A.; Dalladaku, F.; Rosendahl, U.; Ennker, J.; Florath, Ines (2011)Objective: Midterm clinical outcome was evaluated after aortic root replacement with Freestyle ® stentless aortic root bioprostheses. Methods: Between April 1996 and December 2007, 301 patients underwent aortic valve ...
Russell, E.; Walsh, W.; Reid, Christopher; Tran, L.; Brown, A.; Bennetts, J.; Baker, R.; Tam, R.; Maguire, G. (2017)Objective: To further the understanding of the factors influencing outcome following rheumatic heart disease (RHD) related mitral valve surgery, which globally remains an important cause of heart disease and a particular ...